Avraham Minkowitz
CIK: 0002110204
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KALA
KALA BIO, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Minkowitz Avraham
Minkowitz Avraham (SEC CIK 0002110204) files insider reports with the SEC as Chief Executive Officer of KALA BIO, Inc. (KALA).
Signal8 holds 1 ownership filing by Minkowitz Avraham, a Form 3, filed on Feb 9, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Minkowitz Avraham's filings is in ARLINGTON, MA.
Other insiders filing for KALA BIO, Inc. (KALA)
- Purdy Brendan P., Director
- Posen Hillel D., Director
- Colman Yonatan C., Director
- Berger Chaim D., Director
- Lazar David E., Chief Executive Officer
- OXFORD FINANCE LLC, 10% Owner